PMA device
Biolon (1% Sodium Hyaluronate for Ophthalmic Surgery)
Altacor , Ltd. · Aid, Surgical, Viscoelastic (LZP, Class III) · First FDA decision Apr 1, 2002, newest Jan 27, 2005Cataract
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
PMA pathway
Device trials
772
Naming "Biolon"
MAUDE reports
17
Brand "Biolon", since 2015
PubMed studies
35
Mentioning "Biolon"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Biolon (1% Sodium Hyaluronate for Ophthalmic Surgery)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
- BIOLON (1% SODIUM HYALURONATE FOR OPHTHALMIC SURGERY)PMA supplement
P960011-S009 · Decided Jan 27, 2005 · 202 days after receipt · Normal 180 Day Track
Device type: AID, SURGICAL, VISCOELASTIC (LZP) · Ophthalmology
- BIOLON(1% SODIUM HYALURONATE FOR OPHTHALMIC SURGERY)PMA supplement
P960011-S008 · Decided Apr 1, 2002 · 14 days after receipt · Normal 180 Day Track
Device type: AID, SURGICAL, VISCOELASTIC (LZP) · Ophthalmology
- BIOLON (1% SODIUM HYALURONATE FOR OPHTHALMIC SURGERY)PMA supplement
P960011-S007 · Decided Nov 1, 2002 · 450 days after receipt · Normal 180 Day Track
Device type: AID, SURGICAL, VISCOELASTIC (LZP) · Ophthalmology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Biolon", any status and sponsor, newest update first.
- Hyaluronic Acid Barrier in ParotidectomyNot yet recruiting
Milton S. Hershey Medical CenterAcademic, hospital or other
NCT07941011 · 20 participants (planned) · Start Jan 1, 2027 · Primary completion Jan 31, 2029
Device: Axoguard HA+ Nerve Protector · For: Parotidectomy, Patient-reported Outcomes; Parotid Cancer; Parotid Gland Tumor and 2 more
- Halova Vaginal Ovules Versus Vaginal Estriol for Genitourinary Symptoms in Postmenopausal WomenCompleted
Perfect Care DistributionNot on our public-company list
NCT07932990 · 252 participants · Start Mar 7, 2025 · Primary completion Apr 22, 2026
Device: Halova vaginal ovules · For: Genitourinary Syndrome of Menopause (GSM); Vaginal Dryness; Vulvo Vaginal Atrophy (VVA)
Sites: Arad, Romania
- Investigating Age Dependence of Fibroblast and Extracellular Matrix Responses to Cross-linked Hyaluronic Acid Filler in Human SkinActive, not recruiting
University of MichiganAcademic, hospital or other
NCT06195605 · 15 participants (planned) · Start May 9, 2024 · Primary completion Nov 2027
Device: Restylane-L; Vehicle · For: Photoaging
Sites: Ann Arbor, Michigan
769 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Biolon", and for the whole product code for context.
This brand
17 reports: 0 malfunction, 17 injury, 0 death
Whole product code LZP
1,607 reports: 550 malfunction, 1,056 injury, 0 death
Newest reports for this brand
- BIOLONInjury
3039186269-2026-00003 · Received Aug 18, 2026
Device type: Aid, Surgical, Viscoelastic (LZP)
Device problem as coded: Insufficient Device Problem Information
Patient problem as coded: Eye Injury
- BIOLONInjury
3039186269-2026-00007 · Received Aug 18, 2026
Device type: Aid, Surgical, Viscoelastic (LZP)
Device problem as coded: Insufficient Device Problem Information
Patient problem as coded: Eye Injury
- BIOLONInjury
3039186269-2026-00010 · Received Aug 18, 2026
Device type: Aid, Surgical, Viscoelastic (LZP)
Device problem as coded: Insufficient Device Problem Information
Patient problem as coded: Eye Injury
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0606-2011 · Started Oct 4, 2010 · Posted by FDA Dec 16, 2010
Reason given: Finger flange on the BD 1% OVD syringe can disengage during cataract surgery and and may lead to injury.
Cause as FDA categorized it: Component design/selection · Device type: Aid, Surgical, Viscoelastic (LZP)
Published research
The most relevant PubMed records for "Biolon"[tiab]. The summary above synthesizes these.
- In vitro cytotoxicity of different thermoplastic materials for clear aligners.
Martina S, Rongo R, Bucci R, et al. · Angle Orthod · 2019
- Resistance of PETG Materials on Thermocycling and Brushing.
imunovik L, Blagec T, Me¡trovik S · Dent J (Basel) · 2023
- Scheimpflug photography study of ophthalmic viscosurgical devices during simulated cataract surgery.
Holmén J Jö, Lundgren B · J Cataract Refract Surg · 2003Comparative Study, Research Support, Non-U.S. Gov't
- Surface Quality Evaluation of Removable Thermoplastic Dental Appliances Related to Staining Beverages and Cleaning Agents.
Porojan L, Vasiliu RD, Porojan SD, et al. · Polymers (Basel) · 2020
- Force degradation study on aligner plates immersed in various solutions.
Chen SM, Huang TH, Ho CT, et al. · J Dent Sci · 2023
- Protective effect of different ophthalmic viscosurgical devices on corneal endothelial cells during phacoemulsification: rabbit model.
Ben-Eliahu S, Tal K, Milstein A, et al. · J Cataract Refract Surg · 2010Comparative Study
- [Study on the thickness-change of different thickness thermoplastic materials after thermoforming and saliva immersion].
Zhang N, Bai YX, Zhang KY, et al. · Hua Xi Kou Qiang Yi Xue Za Zhi · 2010
- Mechanical Properties of Orthodontic Thermoplastics PETG/ PC2858 after Blending.
Ma YS, Fang DY, Zhang N, et al. · Chin J Dent Res · 2016Comparative Study, Research Support, Non-U.S. Gov't
- Preparation and characterization of thermoplastic materials for invisible orthodontics.
Zhang N, Bai Y, Ding X, et al. · Dent Mater J · 2011Research Support, Non-U.S. Gov't
- Mechanical Properties of Thermoplastic Polymers for Aligner Manufacturing: In Vitro Study.
Tamburrino F, D'Antò V, Bucci R, et al. · Dent J (Basel) · 2020
- [Mechanical properties of thermoplastic materials].
Zhang N, Bai YX, Zhang KY · Zhonghua Yi Xue Za Zhi · 2010Comparative Study, English Abstract
- Influence of Water Storage on the Mechanical Properties of 3D-Printed Aligners: An In Vitro Study.
Puchert K, Ritzert P, Wille S, et al. · Bioengineering (Basel) · 2025
Other devices of this type
Also filed under product code LZP.
- PROVISC Ophthalmic Viscosurgical DeviceAlcon Research, Ltd. · PMA 2026
- Sodium Hyaluronate Ophthalmic Viscoelastic Devices (OVD)Johnson & Johnson Surgical Vision, Inc. · PMA 2024
- Amvisc & Amvisc Plus OvdBausch & Lomb, Inc. · PMA 2017
- Staarvisc II & Shellgel Sodium HyauronateAnika Therapeutics, Inc. · PMA 2012
- VISCOAT Ophthalmic Viscosurgical DeviceAlcon Laboratories · PMA 2026
- DISCOVISC Ophthalmic Viscosurgical DeviceAlcon Laboratories · PMA 2021
- Cellugel(R) Ophthalmic Viscosurgical DeviceAlcon Laboratories · PMA 2016
- Ocucoat (2% Hydroxpropylmethylcellulose Solution)Bausch & Lomb, Inc. · PMA 2012
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.